Emanuela Izzo

693 total citations
21 papers, 540 citations indexed

About

Emanuela Izzo is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Emanuela Izzo has authored 21 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 7 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Emanuela Izzo's work include Neuroscience and Neuropharmacology Research (5 papers), Glycogen Storage Diseases and Myoclonus (4 papers) and Lysosomal Storage Disorders Research (4 papers). Emanuela Izzo is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Glycogen Storage Diseases and Myoclonus (4 papers) and Lysosomal Storage Disorders Research (4 papers). Emanuela Izzo collaborates with scholars based in United States, Italy and Canada. Emanuela Izzo's co-authors include George F. Koob, Pietro Paolo Sanna, Laurent Grégoire, Robert Schwarcz, Paolo Guidetti, Pershia Samadi, Arash Rassoulpour, Luigi Pulvirenti, Cristina Orsini and Alessandro Guidotti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Neuroscience and PLoS ONE.

In The Last Decade

Emanuela Izzo

19 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emanuela Izzo United States 12 262 173 138 128 108 21 540
Ayşe Karson Türkiye 14 157 0.6× 109 0.6× 53 0.4× 208 1.6× 181 1.7× 26 553
Bertha Prieto-Gómez Mexico 15 200 0.8× 108 0.6× 96 0.7× 89 0.7× 78 0.7× 27 536
Christopher Barkus United Kingdom 7 349 1.3× 191 1.1× 76 0.6× 71 0.6× 96 0.9× 7 591
Silvina L. Diaz Argentina 14 350 1.3× 157 0.9× 106 0.8× 58 0.5× 59 0.5× 27 595
Andrew C. Morse United States 14 352 1.3× 136 0.8× 78 0.6× 26 0.2× 93 0.9× 20 549
Hadile Ounallah-Saad Israel 6 133 0.5× 184 1.1× 99 0.7× 186 1.5× 127 1.2× 8 612
О. Е. Зубарева Russia 16 397 1.5× 256 1.5× 64 0.5× 76 0.6× 92 0.9× 57 669
K. Yu. Sarkisova Russia 14 511 2.0× 168 1.0× 165 1.2× 56 0.4× 95 0.9× 70 821
Yiu Chung Tse Canada 14 255 1.0× 170 1.0× 107 0.8× 137 1.1× 178 1.6× 20 633
T. Tadano Japan 12 180 0.7× 135 0.8× 81 0.6× 38 0.3× 31 0.3× 35 469

Countries citing papers authored by Emanuela Izzo

Since Specialization
Citations

This map shows the geographic impact of Emanuela Izzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emanuela Izzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emanuela Izzo more than expected).

Fields of papers citing papers by Emanuela Izzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emanuela Izzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emanuela Izzo. The network helps show where Emanuela Izzo may publish in the future.

Co-authorship network of co-authors of Emanuela Izzo

This figure shows the co-authorship network connecting the top 25 collaborators of Emanuela Izzo. A scholar is included among the top collaborators of Emanuela Izzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emanuela Izzo. Emanuela Izzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
MacCarrick, Gretchen, Swaroop Aradhya, Emanuela Izzo, et al.. (2024). Clinical utility of comprehensive gene panel testing for common and rare causes of skeletal dysplasia and other skeletal disorders: Results from the largest cohort to date. American Journal of Medical Genetics Part A. 194(9). e63646–e63646. 1 indexed citations
2.
Truty, Rebecca, Dianalee McKnight, Britt Johnson, et al.. (2022). Value of genetic testing for pediatric epilepsy: Driving earlier diagnosis of ceroid lipofuscinosis type 2 Batten disease. Epilepsia. 63(7). e68–e73. 8 indexed citations
3.
Izzo, Emanuela, Eija H. Seppälä, Kirsi Alakurtti, et al.. (2021). Next-generation sequencing in childhood-onset epilepsies: Diagnostic yield and impact on neuronal ceroid lipofuscinosis type 2 (CLN2) disease diagnosis. PLoS ONE. 16(9). e0255933–e0255933. 6 indexed citations
4.
Zanetti, Alessandra, Francesca D’Avanzo, Moeenaldeen AlSayed, et al.. (2021). Molecular basis of mucopolysaccharidosis IVA (Morquio A syndrome): A review and classification of GALNS gene variants and reporting of 68 novel variants. Human Mutation. 42(11). 1384–1398. 22 indexed citations
5.
Fietz, Michael, Moeenaldeen AlSayed, Derek Burke, et al.. (2016). Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis. Molecular Genetics and Metabolism. 119(1-2). 160–167. 67 indexed citations
6.
Izzo, Emanuela, et al.. (2010). Adjuvant activity of the novel sodium channel blocker NW-3509 in combination therapy with antipsychotics. 1 indexed citations
7.
Colombo, Elena, et al.. (2010). Ion Channel Blockers for the Treatment of Neuropathic Pain. Future Medicinal Chemistry. 2(5). 803–842. 13 indexed citations
8.
Grégoire, Laurent, Arash Rassoulpour, Paolo Guidetti, et al.. (2007). Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys. Behavioural Brain Research. 186(2). 161–167. 75 indexed citations
9.
10.
Samadi, Pershia, Laurent Grégoire, Arash Rassoulpour, et al.. (2005). Effect of kynurenine 3‐hydroxylase inhibition on the dyskinetic and antiparkinsonian responses to levodopa in parkinsonian monkeys. Movement Disorders. 20(7). 792–802. 39 indexed citations
11.
Izzo, Emanuela, Pietro Paolo Sanna, & George F. Koob. (2005). Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor. Pharmacology Biochemistry and Behavior. 81(4). 701–708. 45 indexed citations
12.
Izzo, Emanuela, Rémi Martin‐Fardon, George F. Koob, Friedbert Weiss, & Pietro Paolo Sanna. (2002). Neural plasticity and addiction: PI3-kinase and cocaine behavioral sensitization. Nature Neuroscience. 5(12). 1263–1264. 52 indexed citations
13.
Orsini, Cristina, Emanuela Izzo, George F. Koob, & Luigi Pulvirenti. (2002). Blockade of nitric oxide synthesis reduces responding for cocaine self-administration during extinction and reinstatement. Brain Research. 925(2). 133–140. 21 indexed citations
14.
Izzo, Emanuela, James Auta, Francesco Impagnatiello, et al.. (2001). Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines. Proceedings of the National Academy of Sciences. 98(6). 3483–3488. 70 indexed citations
15.
Izzo, Emanuela, Cristina Orsini, George F. Koob, & Luigi Pulvirenti. (2001). A dopamine partial agonist and antagonist block amphetamine self-administration in a progressive ratio schedule. Pharmacology Biochemistry and Behavior. 68(4). 701–708. 35 indexed citations
16.
Izzo, Emanuela, et al.. (1999). Comparison of secretion of a hepatitis C virus glycoprotein in and. Research in Microbiology. 150(3). 179–187. 10 indexed citations
17.
Walker, John R., Michael A. King, Emanuela Izzo, George F. Koob, & Gavril W. Pasternak. (1999). Antagonism of heroin and morphine self-administration in rats by the morphine-6β-glucuronide antagonist 3-O-methylnaltrexone. European Journal of Pharmacology. 383(2). 115–119. 29 indexed citations
18.
Curti, Daniela, et al.. (1995). Effect of a ubiquinone-like molecule on oxidative energy metabolism in rat cortical synaptosomes at different ages. Neurochemical Research. 20(9). 1001–1006. 5 indexed citations
19.
Curti, Daniela, Emanuela Izzo, & G. Benzi. (1994). Alteration of pallidal cholinergic activity in MPTP-treated monkeys: Effect of dihydro-α-ergocryptine (DEK). Neuroscience Letters. 168(1-2). 213–216. 2 indexed citations
20.
Piccinino, F, et al.. (1969). [Histochemical studies on the RNA content of the liver and pancreas of mice in ethionine poisoning].. PubMed. 52(2). 94–101. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayşe Karson Breakdown of academic impact, for papers by Bertha Prieto-Gómez Breakdown of academic impact, for papers by Christopher Barkus Breakdown of academic impact, for papers by Silvina L. Diaz Breakdown of academic impact, for papers by Andrew C. Morse Breakdown of academic impact, for papers by Hadile Ounallah-Saad Breakdown of academic impact, for papers by О. Е. Зубарева Breakdown of academic impact, for papers by K. Yu. Sarkisova Breakdown of academic impact, for papers by Yiu Chung Tse Breakdown of academic impact, for papers by T. Tadano
Rankless by CCL
2026